Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 7:59:101716.
doi: 10.1016/j.ijcha.2025.101716. eCollection 2025 Aug.

Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center

Daniel Oren  1 , Sunil Ramchandani  1 , Adrian Lorenzana  1 , Ranjit Nair  1 , Julia Szinte  1 , Kian Maalizadeh  1 , Farage Ftiha  1 , Cathrine M Moeller  2 , Andrea Fernandez-Valledor  3 , Roi Bar Cohen  3 , Ignacio Zepeda  1 , Shudhanshu Alishetti  3 , Nino Mihatov  3 , Kumudha Ramasubbu  3 , Ruth Minkin  4 , Anthony Saleh  4 , Manish A Parikh  3 , Franklyn Fenton  1 , Stephen J Peterson  1
Affiliations

Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center

Daniel Oren et al. Int J Cardiol Heart Vasc. .

Abstract

Introduction: Chronic kidney disease (CKD) frequently complicates Congestive Heart Failure (CHF) and can worsen outcomes in cardiogenic shock. Tricuspid Regurgitation (TR), by elevating central venous pressure, may exacerbate renal impairment. Limited data exist regarding CKD's influence in TR interventions. This study assesses the impact of CKD on survival and explores RV dysfunction as a potential mediator in patients with TR in cardiogenic shock.

Methods: We retrospectively analyzed patients admitted with HF-related or myocardial infarction-induced cardiogenic shock (2021-2025). Patients were stratified by TR severity (none/trivial, mild, moderate, severe) and CKD stage. Echocardiographic, laboratory, and hemodynamic data were collected. RV dysfunction was assessed using echocardiography and right heart catheterization. Survival outcomes, including HF readmissions and mortality, were evaluated using Kaplan-Meier analysis and Cox regression, considering predictors significant at p < 0.10.

Results: Among 177 patients (median age 70 years, EF 35 %, 46 % Black), 55 % had CKD. TR severity distribution was: none/trivial 42 %, mild 16 %, moderate 22 %, and severe 20 %. Severe TR significantly increased in-hospital mortality (40 %) compared to non-severe TR (24 %) and correlated with worsening CKD stages. HF readmissions within 12 months occurred in 10 % of patients. Older age and RV dysfunction emerged as the strongest mortality predictors. Severe TR independently increased mortality and readmission risk.

Conclusion: Severe TR significantly worsens survival in cardiogenic shock patients, especially those with advanced CKD, mediated by RV dysfunction. CKD severity assessment may enhance patient stratification for valve interventions. Randomized studies are required to further validate these findings.

Keywords: Cardiogenic shock; Chronic kidney disease; Right ventricular failure; Tricuspid regurgitation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
KM survival curve.
Fig. 2
Fig. 2
Central Figure.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi: 10.1159/000339789. (Epub 2012 Aug 7 PMID: 22890468) - DOI - PubMed
    1. Maeder M.T., Holst D.P., Kaye D.M. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail. 2008;14(10):824–830. doi: 10.1016/j.cardfail.2008.07.236. (Epub 2008 Sep 6 PMID: 19041045) - DOI - PubMed
    1. Besler C., Orban M., Rommel K.P., Braun D., Patel M., Hagl C., Borger M., Nabauer M., Massberg S., Thiele H., Hausleiter J., Lurz P. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2018;11(12):1119–1128. doi: 10.1016/j.jcin.2018.05.002. (PMID: 29929631) - DOI - PubMed
    1. Deuschl F., Schäfer U. Tricuspid valve regurgitation: a challenge for interventional treatment. JACC Cardiovasc Interv. 2018;11(12):1129–1130. doi: 10.1016/j.jcin.2018.05.040. (PMID: 29929632) - DOI - PubMed
    1. Nickenig G., Kowalski M., Hausleiter J., Braun D., Schofer J., Yzeiraj E., Rudolph V., Friedrichs K., Maisano F., Taramasso M., Fam N., Bianchi G., Bedogni F., Denti P., Alfieri O., Latib A., Colombo A., Hammerstingl C., Schueler R. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135(19):1802–1814. doi: 10.1161/CIRCULATIONAHA.116.024848. (Epub 2017 Mar 23 PMID: 28336788) - DOI - PubMed

LinkOut - more resources